Intermittent ST Depression and Prognosis After Myocardial Infarction

This study has been completed.

First Received: May 25, 2000 Last Updated: June 23, 2005 History of Changes

Sponsored by:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00005217

Purpose

To determine if intermittent ST depression (STD) had an independent impact on survival among myocardial infarction patients who participated in the Beta-Blocker Heart Attack Trial (BHAT).

Condition
Cardiovascular Diseases Myocardial Infarction Heart Diseases

MedlinePlus related topics: Depression Heart Attack Heart Diseases

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	April 1988
Estimated Study Completion Date:	March 1991

Show Detailed Description

Eligibility

Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

No eligibility criteria

Contacts and Locations

No Contacts or Locations Provided

More Information

Publications:

Ruberman W, Crow R, Rosenberg CR, Rautaharju PM, Shore RE, Pasternack BS. Intermittent ST depression and mortality after myocardial infarction. Circulation. 1992 Apr;85(4):1440-6.

Rosenberg CR, Shore RE, Pasternack BS. Height and mortality after myocardial infarction. J Community Health. 1995 Aug;20(4):335-43.

Study ID Numbers:	1096
Study First Received:	May 25, 2000
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00005217 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Necrosis
Depression
Heart Diseases
Myocardial Ischemia
Vascular Diseases

Ischemia
Depressive Disorder
Infarction
Myocardial Infarction

Additional relevant MeSH terms:

Necrosis
Pathologic Processes
Heart Diseases
Myocardial Ischemia
Vascular Diseases

Cardiovascular Diseases
Ischemia
Infarction
Myocardial Infarction

ClinicalTrials.gov processed this record on May 07, 2009